Analysis – Page 12 – Goldea Capital

NexLiving Communities Reports Record Q3 2025 Results and Declares Quarterly Dividend

Written by Customer Service on November 14, 2025. Posted in Earnings Releases And Operating Results.

HALIFAX, Nova Scotia, Nov. 14, 2025 (GLOBE NEWSWIRE) — NexLiving Communities Inc. (“NexLiving” or the “Company”) announced operating and financial results for the three-month and nine-month periods ended September 30, 2025. Stavro Stathonikos, President & CEO commented: “2025 has so far been a year of strong execution producing a milestone quarter for NexLiving. Q3 FFO per share was the highest ever, having increased +30% year-over-year, driven by both operational improvements and acquisition growth. In late Q2 we brought management of our Saint John portfolio in-house, resulting in a +13% increase in same-property NOI. Our recent Winnipeg acquisition is already contributing to FFO, and as construction progresses on our five-phase Ottawa townhome project, we expect to exercise our cashless option and add high-quality assets...

Picard Reports Third Quarter 2025 Financial Results

Written by Customer Service on November 14, 2025. Posted in Earnings Releases And Operating Results.

– Completes IPO, Expands Patent Portfolio, and Strengthens Board Independence – TUCSON, Ariz., Nov. 14, 2025 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced financial results for the three and nine months ended September 30, 2025. Patrick NJ Schnegelsberg, Chief Executive Officer of Picard Medical, Inc., commented, “The third quarter marked a pivotal moment for the company with the successful completion of its initial public offering in September. The IPO strengthened the balance sheet by retiring convertible debt, providing new capital to accelerate research, development, and commercial expansion across SynCardia’s life-saving artificial...

Atlas Energy Reports Third Quarter 2025 Financial Results

Written by Customer Service on November 14, 2025. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, Nov. 14, 2025 (GLOBE NEWSWIRE) — Atlas Energy Corp. (“Atlas” or the “Company”) (TSXV: ATLE), a TSXV Sandbox issuer, is pleased to announce its unaudited consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the quarter ended September 30, 2025, are available on the Company’s SEDAR+ profile at www.sedarplus.ca. “The recent moderation in global oil prices and emerging forecasts for a potential oversupply in 2026 have added to an already constructive environment for disciplined capital deployment. These market dynamics have contributed to a meaningful expansion of Atlas’s deal pipeline over the last few months and strengthened the visibility of near-term actionable opportunities”, said Mark Hodgson, Atlas Energy’s President and Chief Executive Officer. “Within...

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2025 Financial Results

Written by Customer Service on November 14, 2025. Posted in Earnings Releases And Operating Results.

Day One Biopharmaceuticals, Inc. to Acquire Mersana Therapeutics, Inc. Agreement provides for upfront consideration of $25.00 per share in cash, plus potential contingent value rights cash payments of up to an aggregate of $30.25 per share, for aggregate deal value of up to approximately $285 million Closing is expected to occur by the end of January 2026CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today provided a business update and reported financial results for the third quarter ended September 30, 2025. Acquisition by Day One Biopharmaceuticals, Inc. Yesterday, Mersana announced that it has entered into a definitive...

AtlasClear Holdings Reports Fiscal First Quarter 2026 Results and Provides Corporate Update Including Elimination of Prior Going Concern Uncertainty

Written by Customer Service on November 14, 2025. Posted in Earnings Releases And Operating Results.

Earnings Call Scheduled for Friday, November 14, 2025, at 8:30 AM ET $20 Million in New Financing Completed Subsequent to Quarter-End De-SPAC Liabilities Reduced by Over 80% Since Fiscal 2024 Stockholders’ Equity Positive at $6.9 Million Third Correspondent Clearing Customer Signed and OnboardingTAMPA, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) — AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear Holdings” or the “Company”) today announced its financial results for the fiscal first quarter ended September 30, 2025, and provided a corporate update. The Company will host its earnings conference call this morning at 8:30 AM Eastern Time. “This quarter marks a key inflection point for AtlasClear,” said John Schaible, Executive Chairman of AtlasClear Holdings. “We have achieved positive stockholders’ equity, continued to streamline...

AmpliTech Group, Inc. Reports Record Strong Q3 2025 Results

Written by Customer Service on November 14, 2025. Posted in Earnings Releases And Operating Results.

Substantially Exceeds Analyst Estimates, Achieves 115% Revenue Growth HAUPPAUGE, N.Y., Nov. 14, 2025 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (NASDAQ: AMPG), a leading designer, developer, and manufacturer of state-of-the-art signal processing components, low-noise amplifiers (LNAs), and advanced 5G/6G ORAN systems, today announced financial results for the third quarter ended September 30, 2025, marking another milestone toward profitability and continued operational momentum. Q3 2025 Financial HighlightsQuarterly revenue of $6.09 million, a 115% increase compared to $2.83 million in Q3 2024. Gross profit more than doubled to $2.96 million, representing a 48.6% gross margin, up from 47.5% in the prior-year period, up about 40% from Q2 2025 gross margins. Net loss significantly narrowed to $188,000 or $0.01 per share, compared...

Alpha Modus Escalates AI-Retail Enforcement Campaign as New Lawsuit Advances Plan to Dominate AI-for-Retail

Written by Customer Service on November 14, 2025. Posted in Public Companies.

CORNELIUS, N.C., Nov. 14, 2025 (GLOBE NEWSWIRE) — Alpha Modus, Corp. (“Alpha Modus”), the subsidiary of Alpha Modus Holdings, Inc. (NASDAQ:AMOD), a vertical AI company driving real-time, in-store shopper engagement and attribution, today announced that it has filed a patent infringement lawsuit against AtliQ Technologies Pvt. Ltd. in the United States District Court for the Eastern District of Texas (Case No. 2:25-cv-01120).The complaint asserts infringement of four U.S. patents: Nos. 10,360,571, 10,977,672, 11,042,890, and 12,039,550. According to the complaint, AtliQ’s AI-powered retail systems, including smart shelf management, targeted advertising and digital signage, and retail analytics solutions, use computer vision, sensor fusion, and cloud analytics that practice the same patented methods central to Alpha Modus’s ecosystem. “Enforcement...

Viewbix Refines Proposed Quantum X Labs Acquisition Terms – Reduces Initial Equity to 40%

Written by Customer Service on November 14, 2025. Posted in Public Companies.

According to the Updated Non-Binding Term Sheet, Performance-Based Earn-Outs Can Reach Up to 65% Tel Aviv, Israel, Nov. 14, 2025 (GLOBE NEWSWIRE) — Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), a global developer of ad-tech innovative technologies accelerating into quantum and AI, today announced the signing of an updated non-binding term sheet with Quantum X Labs Ltd. (“Quantum”) and its shareholders, refining the proposed terms previously announced strategic acquisition. Building on the November 5, 2025 announcement, the revised terms reduce Viewbix’s initial equity issuance to 40.0% of its post-closing issued and outstanding capital stock, inclusive of shares issued concurrently via a PIPE financing of $3 million that the Company announced on November 5, 2025, issuable in shares of its common stock and pre-funded...

Legence Reports Third Quarter 2025 Financial Results

Written by Customer Service on November 14, 2025. Posted in Earnings Releases And Operating Results.

Record Quarterly Revenues of $708.0 Million, a 26% Increase from a Year Ago Quarterly Adjusted EBITDA (non-GAAP) Increased 39% from Prior Year Record Total Backlog and Awards of $3.1 Billion, 29% Increase from a Year Ago, with Robust Book-to-Bill of 1.5x Signed Definitive Agreement to Acquire Bowers, a Premier Mechanical Contractor in the Northern Virginia/DC MetroArea for Total Consideration of $475 Million Tuck-In Acquisitions of Engineering Firm and Mechanical Contractor Provide Cross Selling Opportunities andAccess to Strategic End Markets Total Debt and Net Debt (non-GAAP) Declines to $836 Million and $650 Million, respectively, on IPO Proceedsand Strong Cash Generation1 Establish Fourth Quarter 2025 Guidance for Revenue of $600 Million – $630 Million and Non-GAAP AdjustedEBITDA of $60 Million...

AMG Announces Conversion Rate Adjustment for its 5.15% Junior Convertible Trust Preferred Securities Due 2037

Written by Customer Service on November 14, 2025. Posted in Public Companies.

WEST PALM BEACH, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) — AMG, a strategic partner to leading independent investment management firms globally, today announced an adjustment to the conversion rate of its 5.15% junior convertible trust preferred securities due 2037 (the “junior convertible securities”). The conversion rate adjustment is being made in accordance with the indenture governing the conversion of the junior convertible securities as a result of the quarterly cash dividends paid by AMG on common shares since the fourth quarter of 2019 through the previously announced quarterly cash dividend with an ex-dividend date of November 13, 2025 to be paid on November 28, 2025. Effective immediately, the conversion rate is adjusted from 0.2558 common shares per $50.00 junior convertible security to 0.2582 common shares per $50.00...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals